On the benefits and harms of screening for breast cancer
Open Access
- 1 February 2004
- journal article
- editorial
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 33 (1) , 56-64
- https://doi.org/10.1093/ije/dyh014
Abstract
In their qualitative review,1 Freedman, Petitti and Robins (FPR) claim that our critique of the randomized screening trials has little merit; that there is no reason to believe that the Canadian study was of better quality than the New York Health Insurance Plan (HIP) study or the Two-County study; and that the prior consensus on mammography was correct. However, their review suffers from erroneous assumptions and biased statistical analyses, and their quotations are often selective and misleading. In my discussion of the issues, I will follow when possible the sequence of arguments used by FPR.Keywords
This publication has 0 references indexed in Scilit: